missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Cynomolgus Monkey CD40/TNFRSF5 Fc Chimera
Click to view available options
Quantity:
100 μg
Unit Size:
100µg
Description
Measured by its binding ability in a functional ELISA. When Recombinant Cynomolgus Monkey CD40/TNFRSF5 Fc Chimera is coated at 1 μg/mL, 100 μL/well, it binds to Recombinant Human CD40 Ligand/TNFSF5 (Catalog # 6420-CL ) with an ED50 of 5-25 ng/mL.
Specifications
Specifications
| Accession Number | XP_005569274.1 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Gene ID (Entrez) | 958 |
| Molecular Weight (g/mol) | M.W. (Observed): 57-64 kDa, reducing conditions; M.W. (theoretical): 46 kDa |
| Name | B cell surface antigen CD40, B-cell surface antigen CD40, Bp50B cell-associated molecule, CD40, CD40 antigen, CD40 molecule, TNF receptor superfamily member 5, CD40 type II isoform, CD40L receptor, CDw40, MGC9013, nerve growth factor receptor-related B-lymphocyte activation molecule, p50, TNFRSF5, TNFRSF5CD40 antigen (TNF receptor superfamily member 5), tumor necrosis factor receptor superfamily member 5, tumor necrosis factor receptor superfamily, member 5 |
| Quantity | 100 μg |
| Source | Human embryonic kidney cell, HEK293-derived cynomolgus monkey CD40/TNFRSF5 protein Cynomolgus Monkey CD40/TNFRSF5 (Glu21-Arg193) (N-terminus) Accession # XP_005569274.1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction